PAYS logo

Paysign Inc. (PAYS)

$9.81

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on PAYS

Market cap

$557741017

EPS

0.33

P/E ratio

56.9

Price to sales

8.62

Dividend yield

--

Beta

0.919477

Price on PAYS

Previous close

$9.54

Today's open

$9.55

Day's range

$9.48 - $10.01

52 week range

$3.08 - $16.15

Profile about PAYS

CEO

Mark R. Newcomer

Employees

226

Headquarters

Henderson, NV

Exchange

NASDAQ Capital Market

Shares outstanding

56854334

Issue type

Common Stock

PAYS industries and sectors

Finance

Diversified Financial Services

News on PAYS

Paysign: 3 Key Takeaways for Long-Term Investors

Pharma patient affordability revenue grew 110% year-over-year to $16.6 million. Losing 113 plasma centers reduces fourth-quarter revenue by $1.5 million.

news source

The Motley Fool • Nov 15, 2026

news preview

Down 39.2% in 4 Weeks, Here's Why Paysign (PAYS) Looks Ripe for a Turnaround

Paysign (PAYS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

news source

Zacks Investment Research • Nov 13, 2026

news preview

All You Need to Know About Paysign (PAYS) Rating Upgrade to Buy

Paysign (PAYS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

news source

Zacks Investment Research • Nov 13, 2026

news preview

Is Paysign (PAYS) a Solid Growth Stock? 3 Reasons to Think "Yes"

Paysign (PAYS) possesses solid growth attributes, which could help it handily outperform the market.

news source

Zacks Investment Research • Nov 13, 2026

news preview

Paysign's Post-Q3 Selloff Opens An Opportunity

Paysign is rated a Buy at $10 despite losing a major plasma customer, as the selloff is seen as exaggerated. The Pharma segment now drives over half of revenue, growing 110% with higher margins and a larger TAM, offsetting plasma center losses. Management raised guidance for revenue, gross margin, net income, and EBITDA, projecting continued growth and margin expansion into FY26.

news source

Seeking Alpha • Nov 12, 2026

news preview

Paysign Q3 Earnings Call Highlights

Paysign NASDAQ: PAYS reported record third-quarter revenue, operating income and adjusted EBITDA as growth in its patient affordability business more than offset slower growth in plasma payment processing.

news source

MarketBeat • Nov 10, 2026

news preview

Paysign, Inc. (PAYS) Q3 2026 Earnings Call Transcript

Paysign, Inc. (PAYS) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Nov 10, 2026

news preview

Paysign Reports Record Third Quarter 2026 Revenue of $30.8 Million, Up 43%; Operating Margin More Than Triples to 23.8%

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a provider of patient affordability offerings, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced financial results for the third quarter 2026. Third Quarter 2026 Financial Highlights Revenues of $30.80 million in Q3'26, up 42.6% from Q3'25 Pharma revenue increased 109.8% to $16.62 million in Q3'26 versus Q3'25; added 62 net patient a.

news source

Business Wire • Nov 9, 2026

news preview

Post-Election Hidden Gems: 3 Under-The-Radar Growth Stocks

Favorable post-midterm election momentum, plus annual market seasonality accelerating with Black Friday, could provide powerful tailwinds for equities. Meanwhile, extreme market fear and macroeconomic uncertainty can create attractive buying opportunities in under-the-radar technology companies with strong fundamentals and exceptional long-term growth potential. In this environment, it's important to remain selective, consider company-specific risks, and evaluate appropriate entry points and long-term portfolio allocations.

news source

Seeking Alpha • Nov 5, 2026

news preview

Fintech Leader Vaults 203% To Highs: Earnings On Deck

Fintech stock Paysign scores a new high Friday with a year-to-date gain of 203%. Paysign provides finance tools for several industries.

news source

Investors Business Daily • Oct 16, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Paysign Inc.

Open an M1 investment account to buy and sell Paysign Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in PAYS on M1